Cytodyn Inc (CYDY)

[B52T38]

3 Questions for MD's and Experienced Bio Investors:

1. In your experience, was yesterday's PR unusual? Does a no-revenue bio company typically announce that "trial data has been unblinded and the results will be reported when the Company has concluded its ongoing discussions with regulators?"

2. Was CYDY legally obligated to tell us the trial results were unblinded? If not, do you think they were trying to communicate something more with the PR, i.e., stay the course and don't blink?

3. If the company publishes no 'bad news' re: the study by Friday, does it really mean our CD 12 results have hit the primary endpoint?

Thanks!